Global Chronic Kidney Disease Drugs Market Insights and Forecast to 2028

Report ID: 1154689 | Published Date: Jan 2025 | No. of Page: 113 | Base Year: 2024 | Rating: 4.3 | Webstory: Check our Web story
1 Study Coverage
    1.1 Chronic Kidney Disease Drugs Product Introduction
    1.2 Market by Type
        1.2.1 Global Chronic Kidney Disease Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 ACE Inhibitors
        1.2.3 Calcium Channel Blockers
        1.2.4 Beta Blockers
        1.2.5 Others
    1.3 Market by Application
        1.3.1 Global Chronic Kidney Disease Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Hospitals
        1.3.3 Specialty Clinics
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Chronic Kidney Disease Drugs Sales Estimates and Forecasts 2017-2028
    2.2 Global Chronic Kidney Disease Drugs Revenue Estimates and Forecasts 2017-2028
    2.3 Global Chronic Kidney Disease Drugs Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Chronic Kidney Disease Drugs Sales by Region
        2.4.1 Global Chronic Kidney Disease Drugs Sales by Region (2017-2022)
        2.4.2 Global Sales Chronic Kidney Disease Drugs by Region (2023-2028)
    2.5 Global Chronic Kidney Disease Drugs Revenue by Region
        2.5.1 Global Chronic Kidney Disease Drugs Revenue by Region (2017-2022)
        2.5.2 Global Chronic Kidney Disease Drugs Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Chronic Kidney Disease Drugs Sales by Manufacturers
        3.1.1 Global Top Chronic Kidney Disease Drugs Manufacturers by Sales (2017-2022)
        3.1.2 Global Chronic Kidney Disease Drugs Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Chronic Kidney Disease Drugs in 2021
    3.2 Global Chronic Kidney Disease Drugs Revenue by Manufacturers
        3.2.1 Global Chronic Kidney Disease Drugs Revenue by Manufacturers (2017-2022)
        3.2.2 Global Chronic Kidney Disease Drugs Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Chronic Kidney Disease Drugs Revenue in 2021
    3.3 Global Chronic Kidney Disease Drugs Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Chronic Kidney Disease Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Chronic Kidney Disease Drugs Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Chronic Kidney Disease Drugs Sales by Type
        4.1.1 Global Chronic Kidney Disease Drugs Historical Sales by Type (2017-2022)
        4.1.2 Global Chronic Kidney Disease Drugs Forecasted Sales by Type (2023-2028)
        4.1.3 Global Chronic Kidney Disease Drugs Sales Market Share by Type (2017-2028)
    4.2 Global Chronic Kidney Disease Drugs Revenue by Type
        4.2.1 Global Chronic Kidney Disease Drugs Historical Revenue by Type (2017-2022)
        4.2.2 Global Chronic Kidney Disease Drugs Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Chronic Kidney Disease Drugs Revenue Market Share by Type (2017-2028)
    4.3 Global Chronic Kidney Disease Drugs Price by Type
        4.3.1 Global Chronic Kidney Disease Drugs Price by Type (2017-2022)
        4.3.2 Global Chronic Kidney Disease Drugs Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Chronic Kidney Disease Drugs Sales by Application
        5.1.1 Global Chronic Kidney Disease Drugs Historical Sales by Application (2017-2022)
        5.1.2 Global Chronic Kidney Disease Drugs Forecasted Sales by Application (2023-2028)
        5.1.3 Global Chronic Kidney Disease Drugs Sales Market Share by Application (2017-2028)
    5.2 Global Chronic Kidney Disease Drugs Revenue by Application
        5.2.1 Global Chronic Kidney Disease Drugs Historical Revenue by Application (2017-2022)
        5.2.2 Global Chronic Kidney Disease Drugs Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Chronic Kidney Disease Drugs Revenue Market Share by Application (2017-2028)
    5.3 Global Chronic Kidney Disease Drugs Price by Application
        5.3.1 Global Chronic Kidney Disease Drugs Price by Application (2017-2022)
        5.3.2 Global Chronic Kidney Disease Drugs Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Chronic Kidney Disease Drugs Market Size by Type
        6.1.1 North America Chronic Kidney Disease Drugs Sales by Type (2017-2028)
        6.1.2 North America Chronic Kidney Disease Drugs Revenue by Type (2017-2028)
    6.2 North America Chronic Kidney Disease Drugs Market Size by Application
        6.2.1 North America Chronic Kidney Disease Drugs Sales by Application (2017-2028)
        6.2.2 North America Chronic Kidney Disease Drugs Revenue by Application (2017-2028)
    6.3 North America Chronic Kidney Disease Drugs Market Size by Country
        6.3.1 North America Chronic Kidney Disease Drugs Sales by Country (2017-2028)
        6.3.2 North America Chronic Kidney Disease Drugs Revenue by Country (2017-2028)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Chronic Kidney Disease Drugs Market Size by Type
        7.1.1 Europe Chronic Kidney Disease Drugs Sales by Type (2017-2028)
        7.1.2 Europe Chronic Kidney Disease Drugs Revenue by Type (2017-2028)
    7.2 Europe Chronic Kidney Disease Drugs Market Size by Application
        7.2.1 Europe Chronic Kidney Disease Drugs Sales by Application (2017-2028)
        7.2.2 Europe Chronic Kidney Disease Drugs Revenue by Application (2017-2028)
    7.3 Europe Chronic Kidney Disease Drugs Market Size by Country
        7.3.1 Europe Chronic Kidney Disease Drugs Sales by Country (2017-2028)
        7.3.2 Europe Chronic Kidney Disease Drugs Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Chronic Kidney Disease Drugs Market Size by Type
        8.1.1 Asia Pacific Chronic Kidney Disease Drugs Sales by Type (2017-2028)
        8.1.2 Asia Pacific Chronic Kidney Disease Drugs Revenue by Type (2017-2028)
    8.2 Asia Pacific Chronic Kidney Disease Drugs Market Size by Application
        8.2.1 Asia Pacific Chronic Kidney Disease Drugs Sales by Application (2017-2028)
        8.2.2 Asia Pacific Chronic Kidney Disease Drugs Revenue by Application (2017-2028)
    8.3 Asia Pacific Chronic Kidney Disease Drugs Market Size by Region
        8.3.1 Asia Pacific Chronic Kidney Disease Drugs Sales by Region (2017-2028)
        8.3.2 Asia Pacific Chronic Kidney Disease Drugs Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Chronic Kidney Disease Drugs Market Size by Type
        9.1.1 Latin America Chronic Kidney Disease Drugs Sales by Type (2017-2028)
        9.1.2 Latin America Chronic Kidney Disease Drugs Revenue by Type (2017-2028)
    9.2 Latin America Chronic Kidney Disease Drugs Market Size by Application
        9.2.1 Latin America Chronic Kidney Disease Drugs Sales by Application (2017-2028)
        9.2.2 Latin America Chronic Kidney Disease Drugs Revenue by Application (2017-2028)
    9.3 Latin America Chronic Kidney Disease Drugs Market Size by Country
        9.3.1 Latin America Chronic Kidney Disease Drugs Sales by Country (2017-2028)
        9.3.2 Latin America Chronic Kidney Disease Drugs Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Chronic Kidney Disease Drugs Market Size by Type
        10.1.1 Middle East and Africa Chronic Kidney Disease Drugs Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Chronic Kidney Disease Drugs Revenue by Type (2017-2028)
    10.2 Middle East and Africa Chronic Kidney Disease Drugs Market Size by Application
        10.2.1 Middle East and Africa Chronic Kidney Disease Drugs Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Chronic Kidney Disease Drugs Revenue by Application (2017-2028)
    10.3 Middle East and Africa Chronic Kidney Disease Drugs Market Size by Country
        10.3.1 Middle East and Africa Chronic Kidney Disease Drugs Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Chronic Kidney Disease Drugs Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 Keryx Biopharmaceuticals, Inc
        11.1.1 Keryx Biopharmaceuticals, Inc Corporation Information
        11.1.2 Keryx Biopharmaceuticals, Inc Overview
        11.1.3 Keryx Biopharmaceuticals, Inc Chronic Kidney Disease Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 Keryx Biopharmaceuticals, Inc Chronic Kidney Disease Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Keryx Biopharmaceuticals, Inc Recent Developments
    11.2 Kissei Pharmaceutical Co., Ltd
        11.2.1 Kissei Pharmaceutical Co., Ltd Corporation Information
        11.2.2 Kissei Pharmaceutical Co., Ltd Overview
        11.2.3 Kissei Pharmaceutical Co., Ltd Chronic Kidney Disease Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 Kissei Pharmaceutical Co., Ltd Chronic Kidney Disease Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Kissei Pharmaceutical Co., Ltd Recent Developments
    11.3 AbbVie
        11.3.1 AbbVie Corporation Information
        11.3.2 AbbVie Overview
        11.3.3 AbbVie Chronic Kidney Disease Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 AbbVie Chronic Kidney Disease Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 AbbVie Recent Developments
    11.4 GlaxoSmithKline
        11.4.1 GlaxoSmithKline Corporation Information
        11.4.2 GlaxoSmithKline Overview
        11.4.3 GlaxoSmithKline Chronic Kidney Disease Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 GlaxoSmithKline Chronic Kidney Disease Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 GlaxoSmithKline Recent Developments
    11.5 Sanofi
        11.5.1 Sanofi Corporation Information
        11.5.2 Sanofi Overview
        11.5.3 Sanofi Chronic Kidney Disease Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 Sanofi Chronic Kidney Disease Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 Sanofi Recent Developments
    11.6 F. Hoffmann-La Roche Ltd
        11.6.1 F. Hoffmann-La Roche Ltd Corporation Information
        11.6.2 F. Hoffmann-La Roche Ltd Overview
        11.6.3 F. Hoffmann-La Roche Ltd Chronic Kidney Disease Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 F. Hoffmann-La Roche Ltd Chronic Kidney Disease Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 F. Hoffmann-La Roche Ltd Recent Developments
    11.7 Pfizer
        11.7.1 Pfizer Corporation Information
        11.7.2 Pfizer Overview
        11.7.3 Pfizer Chronic Kidney Disease Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 Pfizer Chronic Kidney Disease Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 Pfizer Recent Developments
    11.8 AstraZeneca
        11.8.1 AstraZeneca Corporation Information
        11.8.2 AstraZeneca Overview
        11.8.3 AstraZeneca Chronic Kidney Disease Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.8.4 AstraZeneca Chronic Kidney Disease Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 AstraZeneca Recent Developments
    11.9 Amgen
        11.9.1 Amgen Corporation Information
        11.9.2 Amgen Overview
        11.9.3 Amgen Chronic Kidney Disease Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.9.4 Amgen Chronic Kidney Disease Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.9.5 Amgen Recent Developments
    11.10 Teva Pharmaceutical Industries
        11.10.1 Teva Pharmaceutical Industries Corporation Information
        11.10.2 Teva Pharmaceutical Industries Overview
        11.10.3 Teva Pharmaceutical Industries Chronic Kidney Disease Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.10.4 Teva Pharmaceutical Industries Chronic Kidney Disease Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.10.5 Teva Pharmaceutical Industries Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Chronic Kidney Disease Drugs Industry Chain Analysis
    12.2 Chronic Kidney Disease Drugs Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Chronic Kidney Disease Drugs Production Mode & Process
    12.4 Chronic Kidney Disease Drugs Sales and Marketing
        12.4.1 Chronic Kidney Disease Drugs Sales Channels
        12.4.2 Chronic Kidney Disease Drugs Distributors
    12.5 Chronic Kidney Disease Drugs Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Chronic Kidney Disease Drugs Industry Trends
    13.2 Chronic Kidney Disease Drugs Market Drivers
    13.3 Chronic Kidney Disease Drugs Market Challenges
    13.4 Chronic Kidney Disease Drugs Market Restraints
14 Key Findings in The Global Chronic Kidney Disease Drugs Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer
List of Tables
    Table 1. Global Chronic Kidney Disease Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of ACE Inhibitors
    Table 3. Major Manufacturers of Calcium Channel Blockers
    Table 4. Major Manufacturers of Beta Blockers
    Table 5. Major Manufacturers of Others
    Table 6. Global Chronic Kidney Disease Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 7. Global Chronic Kidney Disease Drugs Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 8. Global Chronic Kidney Disease Drugs Sales by Region (2017-2022) & (K MT)
    Table 9. Global Chronic Kidney Disease Drugs Sales Market Share by Region (2017-2022)
    Table 10. Global Chronic Kidney Disease Drugs Sales by Region (2023-2028) & (K MT)
    Table 11. Global Chronic Kidney Disease Drugs Sales Market Share by Region (2023-2028)
    Table 12. Global Chronic Kidney Disease Drugs Revenue by Region (2017-2022) & (US$ Million)
    Table 13. Global Chronic Kidney Disease Drugs Revenue Market Share by Region (2017-2022)
    Table 14. Global Chronic Kidney Disease Drugs Revenue by Region (2023-2028) & (US$ Million)
    Table 15. Global Chronic Kidney Disease Drugs Revenue Market Share by Region (2023-2028)
    Table 16. Global Chronic Kidney Disease Drugs Sales by Manufacturers (2017-2022) & (K MT)
    Table 17. Global Chronic Kidney Disease Drugs Sales Share by Manufacturers (2017-2022)
    Table 18. Global Chronic Kidney Disease Drugs Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 19. Global Chronic Kidney Disease Drugs Revenue Share by Manufacturers (2017-2022)
    Table 20. Chronic Kidney Disease Drugs Price by Manufacturers (2017-2022) &(USD/MT)
    Table 21. Global Chronic Kidney Disease Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 22. Global Chronic Kidney Disease Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chronic Kidney Disease Drugs as of 2021)
    Table 23. Chronic Kidney Disease Drugs Manufacturing Base Distribution and Headquarters
    Table 24. Manufacturers Chronic Kidney Disease Drugs Product Offered
    Table 25. Date of Manufacturers Enter into Chronic Kidney Disease Drugs Market
    Table 26. Mergers & Acquisitions, Expansion Plans
    Table 27. Global Chronic Kidney Disease Drugs Sales by Type (2017-2022) & (K MT)
    Table 28. Global Chronic Kidney Disease Drugs Sales by Type (2023-2028) & (K MT)
    Table 29. Global Chronic Kidney Disease Drugs Sales Share by Type (2017-2022)
    Table 30. Global Chronic Kidney Disease Drugs Sales Share by Type (2023-2028)
    Table 31. Global Chronic Kidney Disease Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 32. Global Chronic Kidney Disease Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 33. Global Chronic Kidney Disease Drugs Revenue Share by Type (2017-2022)
    Table 34. Global Chronic Kidney Disease Drugs Revenue Share by Type (2023-2028)
    Table 35. Chronic Kidney Disease Drugs Price by Type (2017-2022) & (USD/MT)
    Table 36. Global Chronic Kidney Disease Drugs Price Forecast by Type (2023-2028) & (USD/MT)
    Table 37. Global Chronic Kidney Disease Drugs Sales by Application (2017-2022) & (K MT)
    Table 38. Global Chronic Kidney Disease Drugs Sales by Application (2023-2028) & (K MT)
    Table 39. Global Chronic Kidney Disease Drugs Sales Share by Application (2017-2022)
    Table 40. Global Chronic Kidney Disease Drugs Sales Share by Application (2023-2028)
    Table 41. Global Chronic Kidney Disease Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 42. Global Chronic Kidney Disease Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 43. Global Chronic Kidney Disease Drugs Revenue Share by Application (2017-2022)
    Table 44. Global Chronic Kidney Disease Drugs Revenue Share by Application (2023-2028)
    Table 45. Chronic Kidney Disease Drugs Price by Application (2017-2022) & (USD/MT)
    Table 46. Global Chronic Kidney Disease Drugs Price Forecast by Application (2023-2028) & (USD/MT)
    Table 47. North America Chronic Kidney Disease Drugs Sales by Type (2017-2022) & (K MT)
    Table 48. North America Chronic Kidney Disease Drugs Sales by Type (2023-2028) & (K MT)
    Table 49. North America Chronic Kidney Disease Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 50. North America Chronic Kidney Disease Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 51. North America Chronic Kidney Disease Drugs Sales by Application (2017-2022) & (K MT)
    Table 52. North America Chronic Kidney Disease Drugs Sales by Application (2023-2028) & (K MT)
    Table 53. North America Chronic Kidney Disease Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 54. North America Chronic Kidney Disease Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 55. North America Chronic Kidney Disease Drugs Sales by Country (2017-2022) & (K MT)
    Table 56. North America Chronic Kidney Disease Drugs Sales by Country (2023-2028) & (K MT)
    Table 57. North America Chronic Kidney Disease Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 58. North America Chronic Kidney Disease Drugs Revenue by Country (2023-2028) & (US$ Million)
    Table 59. Europe Chronic Kidney Disease Drugs Sales by Type (2017-2022) & (K MT)
    Table 60. Europe Chronic Kidney Disease Drugs Sales by Type (2023-2028) & (K MT)
    Table 61. Europe Chronic Kidney Disease Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 62. Europe Chronic Kidney Disease Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 63. Europe Chronic Kidney Disease Drugs Sales by Application (2017-2022) & (K MT)
    Table 64. Europe Chronic Kidney Disease Drugs Sales by Application (2023-2028) & (K MT)
    Table 65. Europe Chronic Kidney Disease Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 66. Europe Chronic Kidney Disease Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 67. Europe Chronic Kidney Disease Drugs Sales by Country (2017-2022) & (K MT)
    Table 68. Europe Chronic Kidney Disease Drugs Sales by Country (2023-2028) & (K MT)
    Table 69. Europe Chronic Kidney Disease Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 70. Europe Chronic Kidney Disease Drugs Revenue by Country (2023-2028) & (US$ Million)
    Table 71. Asia Pacific Chronic Kidney Disease Drugs Sales by Type (2017-2022) & (K MT)
    Table 72. Asia Pacific Chronic Kidney Disease Drugs Sales by Type (2023-2028) & (K MT)
    Table 73. Asia Pacific Chronic Kidney Disease Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 74. Asia Pacific Chronic Kidney Disease Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 75. Asia Pacific Chronic Kidney Disease Drugs Sales by Application (2017-2022) & (K MT)
    Table 76. Asia Pacific Chronic Kidney Disease Drugs Sales by Application (2023-2028) & (K MT)
    Table 77. Asia Pacific Chronic Kidney Disease Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 78. Asia Pacific Chronic Kidney Disease Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 79. Asia Pacific Chronic Kidney Disease Drugs Sales by Region (2017-2022) & (K MT)
    Table 80. Asia Pacific Chronic Kidney Disease Drugs Sales by Region (2023-2028) & (K MT)
    Table 81. Asia Pacific Chronic Kidney Disease Drugs Revenue by Region (2017-2022) & (US$ Million)
    Table 82. Asia Pacific Chronic Kidney Disease Drugs Revenue by Region (2023-2028) & (US$ Million)
    Table 83. Latin America Chronic Kidney Disease Drugs Sales by Type (2017-2022) & (K MT)
    Table 84. Latin America Chronic Kidney Disease Drugs Sales by Type (2023-2028) & (K MT)
    Table 85. Latin America Chronic Kidney Disease Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 86. Latin America Chronic Kidney Disease Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 87. Latin America Chronic Kidney Disease Drugs Sales by Application (2017-2022) & (K MT)
    Table 88. Latin America Chronic Kidney Disease Drugs Sales by Application (2023-2028) & (K MT)
    Table 89. Latin America Chronic Kidney Disease Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 90. Latin America Chronic Kidney Disease Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 91. Latin America Chronic Kidney Disease Drugs Sales by Country (2017-2022) & (K MT)
    Table 92. Latin America Chronic Kidney Disease Drugs Sales by Country (2023-2028) & (K MT)
    Table 93. Latin America Chronic Kidney Disease Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 94. Latin America Chronic Kidney Disease Drugs Revenue by Country (2023-2028) & (US$ Million)
    Table 95. Middle East and Africa Chronic Kidney Disease Drugs Sales by Type (2017-2022) & (K MT)
    Table 96. Middle East and Africa Chronic Kidney Disease Drugs Sales by Type (2023-2028) & (K MT)
    Table 97. Middle East and Africa Chronic Kidney Disease Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 98. Middle East and Africa Chronic Kidney Disease Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 99. Middle East and Africa Chronic Kidney Disease Drugs Sales by Application (2017-2022) & (K MT)
    Table 100. Middle East and Africa Chronic Kidney Disease Drugs Sales by Application (2023-2028) & (K MT)
    Table 101. Middle East and Africa Chronic Kidney Disease Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 102. Middle East and Africa Chronic Kidney Disease Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 103. Middle East and Africa Chronic Kidney Disease Drugs Sales by Country (2017-2022) & (K MT)
    Table 104. Middle East and Africa Chronic Kidney Disease Drugs Sales by Country (2023-2028) & (K MT)
    Table 105. Middle East and Africa Chronic Kidney Disease Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 106. Middle East and Africa Chronic Kidney Disease Drugs Revenue by Country (2023-2028) & (US$ Million)
    Table 107. Keryx Biopharmaceuticals, Inc Corporation Information
    Table 108. Keryx Biopharmaceuticals, Inc Description and Major Businesses
    Table 109. Keryx Biopharmaceuticals, Inc Chronic Kidney Disease Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 110. Keryx Biopharmaceuticals, Inc Chronic Kidney Disease Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 111. Keryx Biopharmaceuticals, Inc Recent Developments
    Table 112. Kissei Pharmaceutical Co., Ltd Corporation Information
    Table 113. Kissei Pharmaceutical Co., Ltd Description and Major Businesses
    Table 114. Kissei Pharmaceutical Co., Ltd Chronic Kidney Disease Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 115. Kissei Pharmaceutical Co., Ltd Chronic Kidney Disease Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 116. Kissei Pharmaceutical Co., Ltd Recent Developments
    Table 117. AbbVie Corporation Information
    Table 118. AbbVie Description and Major Businesses
    Table 119. AbbVie Chronic Kidney Disease Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 120. AbbVie Chronic Kidney Disease Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 121. AbbVie Recent Developments
    Table 122. GlaxoSmithKline Corporation Information
    Table 123. GlaxoSmithKline Description and Major Businesses
    Table 124. GlaxoSmithKline Chronic Kidney Disease Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 125. GlaxoSmithKline Chronic Kidney Disease Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 126. GlaxoSmithKline Recent Developments
    Table 127. Sanofi Corporation Information
    Table 128. Sanofi Description and Major Businesses
    Table 129. Sanofi Chronic Kidney Disease Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 130. Sanofi Chronic Kidney Disease Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 131. Sanofi Recent Developments
    Table 132. F. Hoffmann-La Roche Ltd Corporation Information
    Table 133. F. Hoffmann-La Roche Ltd Description and Major Businesses
    Table 134. F. Hoffmann-La Roche Ltd Chronic Kidney Disease Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 135. F. Hoffmann-La Roche Ltd Chronic Kidney Disease Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 136. F. Hoffmann-La Roche Ltd Recent Developments
    Table 137. Pfizer Corporation Information
    Table 138. Pfizer Description and Major Businesses
    Table 139. Pfizer Chronic Kidney Disease Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 140. Pfizer Chronic Kidney Disease Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 141. Pfizer Recent Developments
    Table 142. AstraZeneca Corporation Information
    Table 143. AstraZeneca Description and Major Businesses
    Table 144. AstraZeneca Chronic Kidney Disease Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 145. AstraZeneca Chronic Kidney Disease Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 146. AstraZeneca Recent Developments
    Table 147. Amgen Corporation Information
    Table 148. Amgen Description and Major Businesses
    Table 149. Amgen Chronic Kidney Disease Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 150. Amgen Chronic Kidney Disease Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 151. Amgen Recent Developments
    Table 152. Teva Pharmaceutical Industries Corporation Information
    Table 153. Teva Pharmaceutical Industries Description and Major Businesses
    Table 154. Teva Pharmaceutical Industries Chronic Kidney Disease Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 155. Teva Pharmaceutical Industries Chronic Kidney Disease Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 156. Teva Pharmaceutical Industries Recent Developments
    Table 157. Key Raw Materials Lists
    Table 158. Raw Materials Key Suppliers Lists
    Table 159. Chronic Kidney Disease Drugs Distributors List
    Table 160. Chronic Kidney Disease Drugs Customers List
    Table 161. Chronic Kidney Disease Drugs Market Trends
    Table 162. Chronic Kidney Disease Drugs Market Drivers
    Table 163. Chronic Kidney Disease Drugs Market Challenges
    Table 164. Chronic Kidney Disease Drugs Market Restraints
    Table 165. Research Programs/Design for This Report
    Table 166. Key Data Information from Secondary Sources
    Table 167. Key Data Information from Primary Sources
List of Figures
    Figure 1. Chronic Kidney Disease Drugs Product Picture
    Figure 3. Global Chronic Kidney Disease Drugs Market Share by Type in 2021 & 2028
    Figure 3. ACE Inhibitors Product Picture
    Figure 4. Calcium Channel Blockers Product Picture
    Figure 5. Beta Blockers Product Picture
    Figure 6. Others Product Picture
    Figure 7. Global Chronic Kidney Disease Drugs Market Share by Application in 2021 & 2028
    Figure 8. Hospitals
    Figure 9. Specialty Clinics
    Figure 10. Chronic Kidney Disease Drugs Report Years Considered
    Figure 11. Global Chronic Kidney Disease Drugs Sales 2017-2028 (K MT)
    Figure 12. Global Chronic Kidney Disease Drugs Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 13. Global Chronic Kidney Disease Drugs Revenue 2017-2028 (US$ Million)
    Figure 14. Global Chronic Kidney Disease Drugs Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 15. Global Chronic Kidney Disease Drugs Sales Market Share by Region (2017-2022)
    Figure 16. Global Chronic Kidney Disease Drugs Sales Market Share by Region (2023-2028)
    Figure 17. North America Chronic Kidney Disease Drugs Sales YoY (2017-2028) & (K MT)
    Figure 18. North America Chronic Kidney Disease Drugs Revenue YoY (2017-2028) & (US$ Million)
    Figure 19. Europe Chronic Kidney Disease Drugs Sales YoY (2017-2028) & (K MT)
    Figure 20. Europe Chronic Kidney Disease Drugs Revenue YoY (2017-2028) & (US$ Million)
    Figure 21. Asia-Pacific Chronic Kidney Disease Drugs Sales YoY (2017-2028) & (K MT)
    Figure 22. Asia-Pacific Chronic Kidney Disease Drugs Revenue YoY (2017-2028) & (US$ Million)
    Figure 23. Latin America Chronic Kidney Disease Drugs Sales YoY (2017-2028) & (K MT)
    Figure 24. Latin America Chronic Kidney Disease Drugs Revenue YoY (2017-2028) & (US$ Million)
    Figure 25. Middle East & Africa Chronic Kidney Disease Drugs Sales YoY (2017-2028) & (K MT)
    Figure 26. Middle East & Africa Chronic Kidney Disease Drugs Revenue YoY (2017-2028) & (US$ Million)
    Figure 27. The Chronic Kidney Disease Drugs Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 28. The Top 5 and 10 Largest Manufacturers of Chronic Kidney Disease Drugs in the World: Market Share by Chronic Kidney Disease Drugs Revenue in 2021
    Figure 29. Global Chronic Kidney Disease Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 30. Global Chronic Kidney Disease Drugs Sales Market Share by Type (2017-2028)
    Figure 31. Global Chronic Kidney Disease Drugs Revenue Market Share by Type (2017-2028)
    Figure 32. Global Chronic Kidney Disease Drugs Sales Market Share by Application (2017-2028)
    Figure 33. Global Chronic Kidney Disease Drugs Revenue Market Share by Application (2017-2028)
    Figure 34. North America Chronic Kidney Disease Drugs Sales Market Share by Type (2017-2028)
    Figure 35. North America Chronic Kidney Disease Drugs Revenue Market Share by Type (2017-2028)
    Figure 36. North America Chronic Kidney Disease Drugs Sales Market Share by Application (2017-2028)
    Figure 37. North America Chronic Kidney Disease Drugs Revenue Market Share by Application (2017-2028)
    Figure 38. North America Chronic Kidney Disease Drugs Sales Share by Country (2017-2028)
    Figure 39. North America Chronic Kidney Disease Drugs Revenue Share by Country (2017-2028)
    Figure 40. U.S. Chronic Kidney Disease Drugs Revenue (2017-2028) & (US$ Million)
    Figure 41. Canada Chronic Kidney Disease Drugs Revenue (2017-2028) & (US$ Million)
    Figure 42. Europe Chronic Kidney Disease Drugs Sales Market Share by Type (2017-2028)
    Figure 43. Europe Chronic Kidney Disease Drugs Revenue Market Share by Type (2017-2028)
    Figure 44. Europe Chronic Kidney Disease Drugs Sales Market Share by Application (2017-2028)
    Figure 45. Europe Chronic Kidney Disease Drugs Revenue Market Share by Application (2017-2028)
    Figure 46. Europe Chronic Kidney Disease Drugs Sales Share by Country (2017-2028)
    Figure 47. Europe Chronic Kidney Disease Drugs Revenue Share by Country (2017-2028)
    Figure 48. Germany Chronic Kidney Disease Drugs Revenue (2017-2028) & (US$ Million)
    Figure 49. France Chronic Kidney Disease Drugs Revenue (2017-2028) & (US$ Million)
    Figure 50. U.K. Chronic Kidney Disease Drugs Revenue (2017-2028) & (US$ Million)
    Figure 51. Italy Chronic Kidney Disease Drugs Revenue (2017-2028) & (US$ Million)
    Figure 52. Russia Chronic Kidney Disease Drugs Revenue (2017-2028) & (US$ Million)
    Figure 53. Asia Pacific Chronic Kidney Disease Drugs Sales Market Share by Type (2017-2028)
    Figure 54. Asia Pacific Chronic Kidney Disease Drugs Revenue Market Share by Type (2017-2028)
    Figure 55. Asia Pacific Chronic Kidney Disease Drugs Sales Market Share by Application (2017-2028)
    Figure 56. Asia Pacific Chronic Kidney Disease Drugs Revenue Market Share by Application (2017-2028)
    Figure 57. Asia Pacific Chronic Kidney Disease Drugs Sales Share by Region (2017-2028)
    Figure 58. Asia Pacific Chronic Kidney Disease Drugs Revenue Share by Region (2017-2028)
    Figure 59. China Chronic Kidney Disease Drugs Revenue (2017-2028) & (US$ Million)
    Figure 60. Japan Chronic Kidney Disease Drugs Revenue (2017-2028) & (US$ Million)
    Figure 61. South Korea Chronic Kidney Disease Drugs Revenue (2017-2028) & (US$ Million)
    Figure 62. India Chronic Kidney Disease Drugs Revenue (2017-2028) & (US$ Million)
    Figure 63. Australia Chronic Kidney Disease Drugs Revenue (2017-2028) & (US$ Million)
    Figure 64. Taiwan Chronic Kidney Disease Drugs Revenue (2017-2028) & (US$ Million)
    Figure 65. Indonesia Chronic Kidney Disease Drugs Revenue (2017-2028) & (US$ Million)
    Figure 66. Thailand Chronic Kidney Disease Drugs Revenue (2017-2028) & (US$ Million)
    Figure 67. Malaysia Chronic Kidney Disease Drugs Revenue (2017-2028) & (US$ Million)
    Figure 68. Philippines Chronic Kidney Disease Drugs Revenue (2017-2028) & (US$ Million)
    Figure 69. Latin America Chronic Kidney Disease Drugs Sales Market Share by Type (2017-2028)
    Figure 70. Latin America Chronic Kidney Disease Drugs Revenue Market Share by Type (2017-2028)
    Figure 71. Latin America Chronic Kidney Disease Drugs Sales Market Share by Application (2017-2028)
    Figure 72. Latin America Chronic Kidney Disease Drugs Revenue Market Share by Application (2017-2028)
    Figure 73. Latin America Chronic Kidney Disease Drugs Sales Share by Country (2017-2028)
    Figure 74. Latin America Chronic Kidney Disease Drugs Revenue Share by Country (2017-2028)
    Figure 75. Mexico Chronic Kidney Disease Drugs Revenue (2017-2028) & (US$ Million)
    Figure 76. Brazil Chronic Kidney Disease Drugs Revenue (2017-2028) & (US$ Million)
    Figure 77. Argentina Chronic Kidney Disease Drugs Revenue (2017-2028) & (US$ Million)
    Figure 78. Middle East and Africa Chronic Kidney Disease Drugs Sales Market Share by Type (2017-2028)
    Figure 79. Middle East and Africa Chronic Kidney Disease Drugs Revenue Market Share by Type (2017-2028)
    Figure 80. Middle East and Africa Chronic Kidney Disease Drugs Sales Market Share by Application (2017-2028)
    Figure 81. Middle East and Africa Chronic Kidney Disease Drugs Revenue Market Share by Application (2017-2028)
    Figure 82. Middle East and Africa Chronic Kidney Disease Drugs Sales Share by Country (2017-2028)
    Figure 83. Middle East and Africa Chronic Kidney Disease Drugs Revenue Share by Country (2017-2028)
    Figure 84. Turkey Chronic Kidney Disease Drugs Revenue (2017-2028) & (US$ Million)
    Figure 85. Saudi Arabia Chronic Kidney Disease Drugs Revenue (2017-2028) & (US$ Million)
    Figure 86. U.A.E Chronic Kidney Disease Drugs Revenue (2017-2028) & (US$ Million)
    Figure 87. Chronic Kidney Disease Drugs Value Chain
    Figure 88. Chronic Kidney Disease Drugs Production Process
    Figure 89. Channels of Distribution
    Figure 90. Distributors Profiles
    Figure 91. Bottom-up and Top-down Approaches for This Report
    Figure 92. Data Triangulation
    Figure 93. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Keryx Biopharmaceuticals, Inc
Kissei Pharmaceutical Co., Ltd
AbbVie
GlaxoSmithKline
Sanofi
F. Hoffmann-La Roche Ltd
Pfizer
AstraZeneca
Amgen
Teva Pharmaceutical Industries
Frequently Asked Questions
Chronic Kidney Disease Drugs report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Chronic Kidney Disease Drugs report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Chronic Kidney Disease Drugs report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

High Strength Bolts

High Strength Bolts market is segmented by Type and by Application. Players, stakeholders, and ot ... Read More

Steel Rope

Steel Rope market is segmented by Type and by Application. Players, stakeholders, and other parti ... Read More

Voltage Stabilizer

Voltage Stabilizer market is segmented by Type and by Application. Players, stakeholders, and oth ... Read More

One-way Bearing

One-way Bearing market is segmented by Type and by Application. Players, stakeholders, and other  ... Read More